Latest Issue
PharmTech
Latest Issue
PharmTech Europe
| Email Newsletters from Pharmaceutical Technology and Pharmaceutical Technology Europe | |||
|
News from Europe's pharmaceutical manufacturing industry coupled with upcoming events, and exclusive articles and interviews from industry experts. |
|||
|
New FDA Strategy to Tackle Imports, Supply Chain
FDA released a new strategy on June 20, 2011, that is aimed at meeting the challenges posed by rapidly rising imports (they’ve quadrupled since 2000) of FDA-regulated products and the growing complexity of the pharmaceutical supply chain. A report titled “Pathway to Global Product Safety and Quality,” calls for four key changes to protect consumers:
“Global production of FDA-regulated goods has exploded over the past 10 years. In addition to an increase in imported finished products, manufacturers increasingly use imported materials and ingredients in their US production facilities, making the distinction between domestic and imported products obsolete,” said FDA Commissioner Margaret A. Hamburg in the announcement. “There has been a perfect storm—more products, more manufacturers, more countries and more access. A dramatic change in strategy must be implemented.” In terms of how the new strategy and changing manufacturing environment will affect the pharmaceutical industry in the future, FDA’s announcement notes the following:
|
|
|||||||||||||||